An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results

被引:11
|
作者
Li, Xia [1 ]
Abramson, Richard G. [1 ,2 ]
Arlinghaus, Lori R. [1 ]
Chakravarthy, Anuradha Bapsi [3 ]
Abramson, Vandana [5 ]
Mayer, Ingrid [4 ]
Farley, Jaime [4 ]
Delbeke, Dominique [2 ]
Yankeelov, Thomas E. [1 ,2 ,5 ,6 ,7 ]
机构
[1] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Radiat Oncol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Oncol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Engn, Biomed Engn, Nashville, TN 37235 USA
[6] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA
[7] Vanderbilt Univ, Canc Biol, Nashville, TN 37235 USA
来源
EJNMMI RESEARCH | 2012年 / 2卷
基金
美国国家卫生研究院;
关键词
breast cancer; longitudinal registration; FDG-PET/CT; treatment response; metabolic monitoring;
D O I
10.1186/2191-219X-2-62
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: By providing estimates of tumor glucose metabolism, F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) can potentially characterize the response of breast tumors to treatment. To assess therapy response, serial measurements of FDG-PET parameters (derived from static and/or dynamic images) can be obtained at different time points during the course of treatment. However, most studies track the changes in average parameter values obtained from the whole tumor, thereby discarding all spatial information manifested in tumor heterogeneity. Here, we propose a method whereby serially acquired FDG-PET breast data sets can be spatially co-registered to enable the spatial comparison of parameter maps at the voxel level. Methods: The goal is to optimally register normal tissues while simultaneously preventing tumor distortion. In order to accomplish this, we constructed a PET support device to enable PET/CT imaging of the breasts of ten patients in the prone position and applied a mutual information-based rigid body registration followed by a non-rigid registration. The non-rigid registration algorithm extended the adaptive bases algorithm (ABA) by incorporating a tumor volume-preserving constraint, which computed the Jacobian determinant over the tumor regions as outlined on the PET/CT images, into the cost function. We tested this approach on ten breast cancer patients undergoing neoadjuvant chemotherapy. Results: By both qualitative and quantitative evaluation, our constrained algorithm yielded significantly less tumor distortion than the unconstrained algorithm: considering the tumor volume determined from standard uptake value maps, the post-registration median tumor volume changes, and the 25th and 75th quantiles were 3.42% (0%, 13.39%) and 16.93% (9.21%, 49.93%) for the constrained and unconstrained algorithms, respectively (p = 0.002), while the bending energy (a measure of the smoothness of the deformation) was 0.0015 (0.0005, 0.012) and 0.017 (0.005, 0.044), respectively (p = 0.005). Conclusion: The results indicate that the constrained ABA algorithm can accurately align prone breast FDG-PET images acquired at different time points while keeping the tumor from being substantially compressed or distorted.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [1] An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results
    Xia Li
    Richard G Abramson
    Lori R Arlinghaus
    Anuradha Bapsi Chakravarthy
    Vandana Abramson
    Ingrid Mayer
    Jaime Farley
    Dominique Delbeke
    Thomas E Yankeelov
    EJNMMI Research, 2
  • [2] Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: Preliminary results
    Atuegwu, Nkiruka C.
    Li, Xia
    Arlinghaus, Lori R.
    Abramson, Richard G.
    Williams, Jason M.
    Chakravarthy, A. Bapsi
    Abramson, Vandana G.
    Yankeelov, Thomas E.
    MEDICAL PHYSICS, 2014, 41 (05)
  • [3] PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
    Antunovic, Lidija
    De Sanctis, Rita
    Cozzi, Luca
    Kirienko, Margarita
    Sagona, Andrea
    Torrisi, Rosalba
    Tinterri, Corrado
    Santoro, Armando
    Chiti, Arturo
    Zelic, Renata
    Sollini, Martina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1468 - 1477
  • [4] 18FDG-PET/CT in staging and measuring the efficacy of neoadjuvant chemotherapy in breast cancer
    Groheux, D.
    Hindie, E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (03): : 315 - 326
  • [5] The Role of FDG PET/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer
    Simsek, Eda Tanrikulu
    Coban, Ezgi
    Atag, Elif
    Gungor, Serkan
    Sari, Murat
    Gurleyik, Gunay
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (07): : 792 - 797
  • [6] Deformable registration for quantifying longitudinal tumor changes during neoadjuvant chemotherapy
    Ou, Yangming
    Weinstein, Susan P.
    Conant, Emily F.
    Englander, Sarah
    Da, Xiao
    Gaonkar, Bilwaj
    Hsieh, Meng-Kang
    Rosen, Mark
    DeMichele, Angela
    Davatzikos, Christos
    Kontos, Despina
    MAGNETIC RESONANCE IN MEDICINE, 2015, 73 (06) : 2343 - 2356
  • [7] FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results
    Buchbender, Christian
    Kuemmel, Sherko
    Hoffmann, Oliver
    Stahl, Alexander R.
    Kimmig, Rainer
    Otterbach, Friedrich
    Ladd, Susanne
    Koeninger, Angela
    Forsting, Michael
    Bockisch, Andreas
    Antoch, Gerald
    Heusner, Till A.
    ACTA RADIOLOGICA, 2012, 53 (06) : 628 - 636
  • [8] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    EJSO, 2013, 39 (12): : 1358 - 1363
  • [9] PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy
    Lidija Antunovic
    Rita De Sanctis
    Luca Cozzi
    Margarita Kirienko
    Andrea Sagona
    Rosalba Torrisi
    Corrado Tinterri
    Armando Santoro
    Arturo Chiti
    Renata Zelic
    Martina Sollini
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1468 - 1477
  • [10] Accuracy of MRI Versus PET/CT in the Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer
    Alshaibani, Noof
    Chandramohan, Janaki Krithika
    Althawadi, Yusuf
    Almusalam, Maryam
    Khairi, Sara S.
    Saif, Hamad S.
    Al Sindi, Khalid
    Aly, Salwa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)